Richard A. Young, Director at Syros Pharmaceuticals, Inc. (SYRS), sold 6,564 shares at $22.09 ($145K) on 2017-07-25, disclosed to the SEC on 2017-07-27.
Open-market sale of $145k SYRS by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $22.09 | 3,282 | $72K | 50.0% |
| 2 | $22.09 | 3,282 | $72K | 50.0% |
| Total | $22.09 avg | 6,564 | $145K | 100% |
| Filing → |
| OMGA | SELL | 2023-06-05 | $40K | — | Filing → |
| OMGA | SELL | 2023-05-03 | $40K | — | Filing → |
| OMGA | SELL | 2023-04-10 | $40K | — | Filing → |